| Product Name | Dihydronarwedine-d3 |
| Product Code | DA-G007-q |
| Chemical name | Dihydronarwedine-d3 |
| Synonyms | (4aS,8aR)-4a,5,7,8,9,10,11,12-Octahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one-d3; 3-Deoxy-1,2-dihydro-3-oxo-galanthamine-d3; 2-Deoxy-2-oxo-lycoramine-d3; Deoxyoxo-lycoramine-d3; 6H-Benzofuro[3a,3,2-ef][2]benzazepine, Galanthamine Deriv.-d3; (-)-Dihydrogalanthaminone-d3; (-)-Lycoraminone-d3; |
| Impurity | NA |
| CAS Number | NA |
| Alternate CAS # | NA |
| Molecular form | C17H18D3NO3 |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 290.37 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | chiral standards,heterocycles,metabolites,impurities,pharmaceutical standards,intermediates,Fine Chemicals,stable isotopes |
| Boiling Point | NA |
| Applications | Dihydronarwedine-d3 is the Isotope labelled analogue of Dihydroarwedine, a metabolite of Galanthamine. Galanthamine is a known selective acetylcholinesterase inhibitor and therapeutic agent for the treatment and prevention of Alzheimer's disease and disorders resulting from reduced neuronal metabolism. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
